Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Does the program cost include the medication
4 mg every week for the whole study 4
Its a triple-agonist peptide , meaning it activates three major systems simultaneously: GLP-1 reduces hunger and slows digestion GIP enhances metabolic efficiency Glucagon increases energy expenditure This combination leads to: Eating less without constant willpower Better blood sugar regulation Increased calorie burn at rest The clinical data is already strong Even in earlier trials, the results were hard to ignore: Up to ~24% total body weight loss in Phase 2 studies Around 17% weight loss in type 2 diabetes patients , alongside improved glucose control Up to 82% reduction in liver fat in individuals with fatty liver disease This isnt just weight lossits full metabolic change
1mL vial, monthly supply
Clinical outcomes depend more on your individual genetic response to semaglutide than the source of the medication
Other times, it means looking at a medication people with bipolar disorder are already taking for something else and asking whether its doing more than expected
